Clearing Brain Clots, Funding Startups, and Making MedTech Sustainable

HAPPY NEW YEAR! Host Tom Salemi squeezes in that salutation one final time in our first episode of DeviceTalks Weekly. In this episode, Managing Editor Kayleen Brown shines the FOMO spotlight on a possible new approach to treating stroke victims. Liane Teplitsky, now executive chair of Executive Chair of the Board of Directors of Carvolix, explains how an early-stage robot could give more interventionalists the power to help stroke victims. Tom Salemi and MassDevice’s Chris Newmarker Vensana Capital Co-founder Justin Klein, MD, as a temporary member of the Newsmaker team where the review the highs and lows of the first full week of the year. Tom and Justin then talk about the state of MedTech venture capital starting with the HSBC annual report. Finally, Chris Newmarker hosts our keynote interview featuring Lisa Anderson, president of Paragonix Technologies, which is upending how donated organs are stored for transportation before transplantation. Newsmakers include the late Tom Fogarty, Teleflex, Staar Surgical, Alcon, W.L. Gore, Conformal, and Johnson & Johnson MedTech. You can access the HSBC report here - https://www.hsbcinnovationbanking.com/us/en/resources/2025-annual-venture-healthcare-report?cid=B:OSOC:10937621680:10893300135 Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:06:40) - Meet Justin Klein, MD, co-founder managing partner, Vensana Capital(00:08:42) - MedTech pioneer Dr. Tom Fogarty passes away at 91(00:14:28) - Teleflex announces leadership transition as CEO Liam Kelly departs, cuts 2025 revenue guidance(00:17:20) - Staar Surgical to terminate Alcon deal after stockholder vote W.L. Gore to acquire left atrial appendage device maker Conformal Medical(00:20:10) - W.L. Gore to acquire left atrial appendage device maker Conformal Medical(00:24:45) - Johnson & Johnson MedTech submits Ottava surgical robot to FDA(00:27:19) - Tom and Justin review HSCB report(00:46:54) - FOMO Interview with Kayleen Brown and Liane Teplitsky(00:57:38) - Keynote interview with Lisa Anderson, President, Paragonix Technologies

Happy New Year DeviceTalkers! We’re excited to start 2026, but not before give a proper goodbye to 2025 by picking our top tech, biggest newsmaker (company or person), and biggest news of the year. Listen the selection from our editorial team – Kayleen Brown, Jim Hammerand, Chris Newmarker, Tom Salemi, and Sean Whooley – and a special guest, Chris Landon, CEO of Natus Medical. Just before we share our final thought, Brown gets a glimpse of the future of Ambulatory Surgery Centers from Oliver Keown, MD, CEO and founder of Oath Surgical. They recording the FOMO interview at DeviceTalks West.  To all of our listeners, thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Thank you from Tom and Kayleen(00:05:05) - Overview of the Episode(00:07:00) - FOMO Interview – Oliver Keown, MD, CEO of Oath Surgical on ASCs(00:17:20) - 2025 Year in Review(00:19:40) - Introduction of Guest Panelist – Chris Landon, CEO, Natus Medical(00:25:20) - Our choices of medical technology of the year(00:47:50) - Newsmaker of the year – Company or Individual(01:01:40) - Biggest news story of the year

In this episode of the DeviceTalks Weekly podcast, we give the entire stage to Medtronic’s surgical robotics business in honor of the FDA’s approving the Hugo RAS system for urological procedures. This episode is sponsored by Confluent Medical Technologies. Visit http://confluentmedical.com/ for more information. First, MassDevice editor Chris Newmarker asks James Porter, MD, a practicing surgeon and CMO of Medtronic’s surgical business, why he sees as a better alternative for hospitals and surgeons. Then, Host Tom Salemi visits with Rajit Kamal, the VP of the company’s surgical robotics building to learn what’s next. How will the company take on the massive incumbent, Intuitive. We’ll also visit with Gayle Grimes, author of MassDevice’s Medtech Market Intelligence Report on surgical robotics. Go here to learn more. https://www.massdevice.com/product/robotic-surgery/ This week’s Newmarker’s Newsmakers are CMR Surgical, Johnson & Johnson MedTech, Olympus, Nephrodite, and Medline. Go here to listen to Rajit Kamal’s first appearance on the DeviceTalks Weekly podcast: https://www.devicetalks.com/velys-inhance-and-other-reasons-why-depuy-synthes-sees-ortho-opportunities-2021s-top-dtw-episodes/ *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:55) - Surgical Report Gayle Grimes(00:10:56) - CMR Surgical wins FDA clearance for next-gen Versius Plus surgical robot in cholecystectomy(00:13:22) - Johnson & Johnson MedTech EP leader Bodner explains recent ASC boost for PFA(00:15:03) - Olympus launches second medtech investment fund with $150M(00:16:08) - Continuous dialysis implant wins FDA Breakthrough Device Designation(00:18:33) - Medline prices $7B IPO, begins trading on Nasdaq(00:23:00) - Confluent Medical, Part 1(00:26:40) - Interview with James Porter, MD, CMO, Robotic Surgical Technologies & Digital Technologies, Medtronic(00:52:43) - Confluent Medical, Part 2(00:56:22) - Interview with Rajit Kamal, VP and GM, Robotic Surgical Technologies, Medtronic

Earned trust becomes leadership capital — and in MedTech, it compounds faster than most leaders realize. In this episode of the Women in MedTech podcast, host Kayleen Brown talks with Edwards Lifesciences’ Sarah Huoh, Corporate Vice President of Public Affairs, about why trust has to be built and demonstrated long before it can be communicated — and what it takes to earn credibility across patients, policy, and teams. Kayleen also welcomes Brittany Mai, Marketing Manager at Confluent Medical Technologies, to discuss what trust looks like across the MedTech ecosystem — how strong partnerships get built, how alignment happens across organizations, and why execution depends on credibility that’s earned over time. Thank you to Confluent Medical Technologies for your support. Visit ➡ https://confluentmedical.com/ *** Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players: https://women-in-medtech.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Why trust matters in MedTech(00:02:13) - Introducing In-studio guest, Brittany Mai, Confluent Medical Technologies(00:17:34) - Start of Keynote Interview with Sarah Huoh, Edwards Lifesciences(00:18:31) - Leadership foundations: first job lessons that still show up in the C-suite(00:29:32) - Career moves with strategy: how Sarah chose roles that widened her impact(00:32:44) - Public affairs as a business function: reputation, policy, and patient trust(00:38:30) - “Team of teams” leadership: alignment, execution, and internal credibility(00:39:23) - Operating at global scale: keeping 16,000 employees anchored on patients(00:42:18) - Patient education as market reality: reducing fear, friction, and confusion(00:48:49) - Trust as leadership capital: demonstrated behavior, not messaging(01:06:52) - Conclusion: key takeaways on earning trust that compounds

In this episode of DeviceTalks Weekly, Host Tom Salemi gets the dos and don’t’s of entrepreneurship with serially successful MedTech leader Ray Cohen. In this keynote address from DeviceTalks West, Cohen delivers a master class on how to build a successful MedTech, using Boston Scientific’s $3.7 billion acquisition as a case study. DeviceTalks Managing Editor Kayleen Brown explores the future of connected health with Dr. Sarah Matt, author of the new book, The Borderless Healthcare Revolution. Go to DrSarahMatt.com to order the book. Thank you to Lighteum Medical for sponsoring this episode of DeviceTalks Weekly. Go to http://lighteum.com/ for more information. Want to meet with Lighteum Medical in person at MD&M West? Book time with them here: https://calendly.com/lighteum-medical/mdmwest  MassDevice’s Chris Newmarker kicks us off with his Newmarker’s Newsmakers – SS Innovations, Boston Scientific, Teleflex, Resmed, Telefex Medical. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:29) - Newmarker's Newsmakers(00:18:51) - Part 1 of interview with Jose Maeso, CTO of Lighteum Medical(00:22:35) - FOMO Interview with Dr. Sarah Matt(00:33:28) - Insights from Ray Cohen on MedTech Success(00:44:18) - Key Elements for Starting a Company(00:48:12) - Part 2 of the interview with Lighteum Medical(00:50:50) - The Role of Clinical Support and Physician Champions(01:00:32) - Navigating the IPO Process and Market Dynamics(01:09:27) - The Acquisition by Boston Scientific and Lessons Learned(01:14:31) - Key Takeaways for Aspiring Entrepreneurs

In this episode of Ortho Innovation Talks, host Tom Salemi sits with Suneethi Gudapati, VP of Research & Development, Enovis™ Bracing & Supports, to discuss how her team is advancing the engineering behind braces and supports across the orthopedic continuum of care. Gudapati shares how Enovis evaluates materials, designs, and patient feedback to improve comfort, usability, and clinical performance across its extensive bracing portfolio, which spans postoperative and preventive use cases. She also discusses how her R&D teams partner across the company to explore future opportunities, from new composite materials to potential AI and connected-health applications, while maintaining a strong focus on unmet needs and the aging, increasingly active patient population. Missed a DeviceTalks Tuesdays webinar? Catch up, on-demand, at: https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4415884/devicetalks-tuesdays for everything you missed in 2025. *** Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode, MassDevice Editor Chris Newmarker talks with Alan Cheng, MD, chief medical officer at Medtronic’s cardiac rhythm management business about the future of medical-grade cardiac monitors like Medtronic LINQ monitors. These tiny devices, placed just under the skin, can collect heart rhythm data and transmit it directly to doctors, like Cheng, who is a practicing electrophysiologist. The LINQ II has a battery life of more than four years. How does its functionality compare to consumer monitors, and can LINQ someday find a role as a health tracking tool sold over the counter? Thank you to Resonetics for sponsoring this podcast episode. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8 In our FOMO interview, Jim Hammerand, managing editor of medical design and outsourcing, talks with Ken Charhut, CEO of Foldax about that start-ups innovative heart valve polymer and manufacturing process. But we kick things off with this week’s Newmarker’s Newsmakers discussion with Host Tom Salemi and Chris Newmarker. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:04:30) - #5 - Surgical robotics market will double over the rest of the decade(00:07:23) - #4 - CMS adds reimbursement for cardiac ablation in ASCs(00:09:14) - #3 - Former Stryker robotics leader named CEO at Olympus' Swan EndoSurgical robotics play and Stryker promotes Spencer Stiles to president, COO(00:13:49) - #2 - Medtronic gets FDA nod for Hugo surgical robot in urologic procedures(00:16:35) - #1 - Johnson & Johnson MedTech to shift to business unit-led structure in 2026(00:20:18) - Interview with Eric Veit, Vice President, Nitinol Business Development, Resonetics(00:23:15) - FOMO – Ken Charhut, CEO, Foldax(00:33:48) - Keynote interview Alan Cheng, MD, chief medical officer, CRM, Medtronic(00:46:25) - Conclusion - Interview with Eric Veit, Vice President, Nitinol Business Development, Resonetics

In this week’s DeviceTalks Podcast, we’re spotlighting two very different leaders shaping the future of surgical robotics. Huge thanks to our sponsor, Murata. First up in our FOMO interview, Tom Salemi speaks with Iman Jeddi, senior vice president and general manager of da Vinci platforms and product operations at Intuitive. Jeddi—who closed out our joint keynotes at DeviceTalks West and RoboBusiness—shares deep insight into Intuitive’s long-term vision and what’s next for the surgical robotics front-runner. Then in our keynote interview, Salemi talked with Anne Osdoit, CEO of Moon Surgical. Osdoit breaks down how the company’s Maestro system—designed to move and stabilize laparoscopic tools—is gaining traction in hospitals and ASCs and carving out a new category in robotic surgery. To learn more about the work Murata is doing in medical devices you can download Murata's Medical Applications Brochure HERE or go to their website murata.com. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of DeviceTalks Weekly, we hear from two of MedTech’s most powerful leaders, each representing different ends of the innovation timeline. Tim Schmid, executive vice president and worldwide chairman of Johnson & Johnson MedTech, lays out the global leaders plan to lead in cardiovascular, surgery, vision, surgical robotics and other high growth businesses. Schmid opened our DeviceTalks West conference last month where he was interviewed by Host Tom Salemi. Thank you to Vantedge Medical for sponsoring this episode. For more information on how Vantedge works with medical device companies, visit: https://vantedgemedical.com/ Then, Josh Makower, the Yock Family Professor and professor of bioengineering at the Stanford Mussallem Center for Biodesign sits down in a FOMO interview with Managing Editor Kayleen Brown. Makower, a battle-tested advocate for MedTech innovators, writes a prescription for helping start-ups, calling on OEMs to provide more support. Makower also keynoted the event. MassDevice editor Chris Newmarker kicks things off with this week’s Newmarker’s Newsmakers – Stryker, Boston Scientific, Siemens Healthineers, Medtronic, Solventum, Abbott and Exact Sciences. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:04:35) - Stryker VP, GM for Robotics and Enabling Technologies is departing(00:06:16) - Boston Scientific, Siemens Healthineers ink 4D ICE catheter development deal(00:08:23) - Do we have bubbles in MedTech?(00:11:26) - Medtronic has a strong Q2 beat on PFA strength(00:16:01) - Solventum to acquire soft tissue repair company Acera Surgical, repurchase $1B in shares(00:18:20) - Abbott confirms plans to acquire Exact Sciences for $21B(00:26:26) - Vantedge Medical – How to Recruit and Retain Talent(00:28:29) - FOMO with Josh Makower - Stanford Mussallem Center for Biodesign(00:37:08) - Vantedge Medical – The importance of metals(00:42:27) - Interview with Tim Schmid, Johnson & Johnson MedTech(00:51:31) - Vantedge Medical – Supply chain concerns

In this episode of Ortho Innovation Talks, host Tom Salemi sits with Brad Batte, President of Enovis™ Regeneration, to discuss how the division is transforming post-operative recovery through bone growth stimulation. He also discusses at-home device compliance, clinical outcomes, and how Enovis is expanding its innovation pipeline to support patients across the full continuum of care. This episode is brought to you by DeviceTalks Tuesdays. Join us for a free week-long webinar series: DeviceTalks "Materials & Manufacturing." *** Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe